Vera Therapeutics, Inc. (VERA)
26.97
-1.13
(-4.02%)
USD |
NASDAQ |
Nov 16, 16:00
26.97
0.00 (0.00%)
After-Hours: 19:06
Vera Therapeutics Net Income (Quarterly) : -93.71M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -93.71M |
| June 30, 2026 | -109.47M |
| March 31, 2026 | -121.03M |
| December 31, 2025 | -91.10M |
| September 30, 2025 | -80.29M |
| June 30, 2025 | -76.53M |
| March 31, 2025 | -51.69M |
| December 31, 2024 | -43.42M |
| September 30, 2024 | -46.63M |
| June 30, 2024 | -33.71M |
| March 31, 2024 | -28.38M |
| December 31, 2023 | -25.66M |
| September 30, 2023 | -20.10M |
| June 30, 2023 | -20.16M |
| Date | Value |
|---|---|
| March 31, 2023 | -30.07M |
| December 31, 2022 | -32.44M |
| September 30, 2022 | -24.68M |
| June 30, 2022 | -14.85M |
| March 31, 2022 | -17.08M |
| December 31, 2021 | -16.85M |
| September 30, 2021 | -7.611M |
| June 30, 2021 | -3.437M |
| March 31, 2021 | -4.714M |
| December 31, 2020 | -42.88M |
| September 30, 2020 | -4.46M |
| June 30, 2020 | -3.604M |
| March 31, 2020 | -2.474M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -134.40M |
| Sarepta Therapeutics, Inc. | -28.46M |
| Twist Bioscience Corp. | -20.62M |
| Oncolytics Biotech, Inc. | -9.705M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 10.28M |
| Total Expenses (Quarterly) | 103.99M |
| EPS Diluted (Quarterly) | -1.299 |
| Enterprise Value | 1.723B |
| Gross Profit Margin (Quarterly) | 62.84% |
| Profit Margin (Quarterly) | -911.9% |
| Earnings Yield | -21.92% |
| Normalized Earnings Yield | -21.92 |